epigallocatechin gallate has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M | 1 |
| Campiani, G; Craig, AG; Gemma, S; Patil, PR | 1 |
2 other study(ies) available for epigallocatechin gallate and Malaria, Falciparum
| Article | Year |
|---|---|
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2010 |
Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate.
Topics: Antimalarials; Catechin; Cell Adhesion; Child; Child, Preschool; Erythrocytes; Humans; Intercellular Adhesion Molecule-1; Malaria, Falciparum; Microscopy; Plasmodium falciparum; Protein Binding | 2011 |